Suberoylanilide hydroxamic acid: A potential epigenetic therapeutic agent for lung fibrosis?
10.1183/09031936.00084808
Saved in:
Main Authors: | Wang, Z., Chen, C., Lareu, R.R., Raghunath, M., Finger, S.N., Do, Kwajah MM S., Schwarz, H., Jung, M., Swanson, N. |
---|---|
Other Authors: | PHYSIOLOGY |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/25157 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents
by: Lin, H.-S., et al.
Published: (2014) -
Epigenetic potential of histone deacetylase inhibitors in treating fibroproliferative diseases and preventing peri-implantational fibrosis
by: WANG ZHIBO
Published: (2010) -
Reversal of phenotype and plasticity of myofibroblasts to target peri-implantation fibrosis
by: TAN BING-SHI, ARIEL
Published: (2013) -
Synergistic effects of suberoylanilide hydroxamic acid combined with cisplatin causing cell cycle arrest independent apoptosis in platinum-resistant ovarian cancer cells
by: Ong, P.-S., et al.
Published: (2014) -
Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-ΚB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells
by: Choo, Q.-Y., et al.
Published: (2014)